Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.

被引：0
|
作者：
Baer, Maria R. [1 ]
Ford, Laurie A. [1 ]
Bundy, Brian N. [1 ]
Tighe, Sheila M. [1 ]
O'Loughlin, Kieran L. [1 ]
Slack, James L. [1 ]
Wetzler, Meir [1 ]
Wallace, Paul K. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4574
引用
收藏
页码：223B / 223B
页数：1
相关论文
共 50 条
  • [31] Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
    Halpern, Anna B.
    Rodriguez-Arboli, Eduardo
    Othus, Megan
    Garcia, Kelsey-Leigh A.
    Percival, Mary-Elizabeth M.
    Cassaday, Ryan D.
    Oehler, Vivian G.
    Becker, Pamela S.
    Appelbaum, Jacob S.
    Abkowitz, Janis L.
    Orozco, Johnnie J.
    Keel, Sioban B.
    Hendrie, Paul C.
    Scott, Bart L.
    Ghiuzeli, M. Cristina
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD ADVANCES, 2023, 7 (17) : 4950 - 4961
  • [32] Safety and activity of venetoclax in combination with high-dose cytarabine in children with relapsed or refractory acute myeloid leukemia.
    Karol, Seth E.
    Alexander, Thomas
    Das Gupta, Soumyasri
    Pounds, Stanley B.
    Canavera, Kristin
    Klco, Jeffery M.
    Lacayo, Norman James
    Pui, Ching-Hon
    Opferman, Joseph T.
    Rubnitz, Jeffrey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
    Becker, Pamela S.
    Kantarjian, Hagop M.
    Appelbaum, Frederick R.
    Petersdorf, Stephen H.
    Storer, Barry
    Pierce, Sherry
    Shan, Jianqin
    Hendrie, Paul C.
    Pagel, John M.
    Shustov, Andrei R.
    Stirewalt, Derek L.
    Faderl, Stephan
    Harrington, Elizabeth
    Estey, Elihu H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) : 182 - 189
  • [34] Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
    Motabi, Ibraheem H.
    Al Aoun, Shaima M.
    Al-Ammari, Maged
    Albtoosh, Belal M.
    Iqbal, Shahid
    Altaf, Syed Y.
    Tailor, Imran K.
    Alnoamani, Mohammed S.
    AlGhamdi, Mubarak S.
    Zaidi, Syed Z. A.
    AlShehry, Nawal F.
    Marei, Mohammed A.
    Alfayez, Mansour
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 720 - 723
  • [35] Autotransplantation of non-cryopreserved, GM-CSF or G-CSF mobilized, peripheral blood progenitor cells (PBPC) after high-dose chemotherapy as a consolidation therapy for acute non-lymphocytic leukemia (ANLL).
    SanchezValle, E
    Gomez, E
    Chavez, G
    Guerrero, S
    Gutierrez, L
    Pizzuto, J
    BLOOD, 1995, 86 (10) : 3842 - 3842
  • [36] A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
    Christian, Sonia
    Arain, Saad
    Patel, Pritesh
    Khan, Irum
    Calip, Gregory S.
    Agrawal, Vaibhav
    Sweiss, Karen
    Griffin, Shawn
    Cahill, Kirk
    Konig, Heiko
    Esen, Aysenur
    Shergill, Ardaman
    Odenike, Olatoyosi
    Stock, Wendy
    Quigley, John G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 937 - 943
  • [37] G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial
    Halpern, Anna B.
    Huebner, Emily M.
    Othus, Megan
    Scott, Bart L.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Gardner, Kelda M.
    Buckley, Sarah A.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2017, 130
  • [38] Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone
    Tuncer, AM
    Hicsonmez, G
    Gumruk, F
    Sayli, T
    Guler, E
    Cetin, M
    Okur, H
    LEUKEMIA RESEARCH, 1996, 20 (03) : 265 - 269
  • [39] FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia
    Huhmann, IM
    Watzke, HH
    Geissler, K
    Gisslinger, H
    Jager, U
    Knobl, P
    Pabinger, I
    Korninger, L
    Mannhalter, C
    Mitterbauer, G
    Schwarzinger, I
    Kalhs, P
    Haas, OA
    Lechner, K
    ANNALS OF HEMATOLOGY, 1996, 73 (06) : 265 - 271
  • [40] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA USING GM-CSF BEFORE INTENSIVE CHEMOTHERAPY
    PUNTOUS, M
    LACOMBE, F
    DUMAIN, P
    MARIT, G
    CONYMAKHOUL, P
    BELLOC, F
    BOIRON, JM
    LAURENT, G
    BERNARD, P
    REIFFERS, J
    LEUKEMIA & LYMPHOMA, 1993, 12 (1-2) : 95 - 102
12345